TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo May 13, 2024 Meeta Vyas Chief Financial Officer NanoViricides, Inc 1 Controls Drive Shelton, CT 06484 Re: NanoViricides, Inc Form 10-K for Fiscal Year Ended June 30, 2023 File No. 001-36081 Dear Meeta Vyas: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences